MedTrace Logo

MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer

NCT00003736 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2019-09-24

No results posted yet for this study

Summary

RATIONALE: Screening tests may help doctors detect cancer cells early and plan more effective treatment for breast cancer. Diagnostic procedures such as MRI may improve the ability to detect breast cancer.

PURPOSE: Screening and diagnostic trial to study the effectiveness of MRI scans in women who are at high risk for developing breast cancer.

Conditions

Interventions

DRUG

motexafin gadolinium

PROCEDURE

biopsy

PROCEDURE

breast imaging study

PROCEDURE

comparison of screening methods

PROCEDURE

magnetic resonance imaging

PROCEDURE

study of high risk factors

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Abramson Cancer Center at Penn Medicine

    lead OTHER

Principal Investigators

  • Mitchell Schnall, PhD · Abramson Cancer Center at Penn Medicine

Study Design

Purpose
SCREENING

Eligibility

Min Age
25 Years
Max Age
120 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-06-30
Primary Completion
2002-06-30
Completion
2002-06-30

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00003736 on ClinicalTrials.gov